Skip to content

Simplified Negative Pressure Wound Therapy

Evaluation of the Performance and Safety of a Simplified Negative Pressure Wound Therapy Device

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01339429
Enrollment
41
Registered
2011-04-20
Start date
2011-03-31
Completion date
2012-02-29
Last updated
2015-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wounds

Keywords

wound, negative pressure wound therapy, non-powered negative pressure wound therapy

Brief summary

The objective of this study is to implement a simplified Negative Pressure Wound Therapy (sNPWT) device in a low resource setting. The investigators hypothesize that the sNPWT device is at least equivalent to commercially available NPWT devices. Therefore, the specific aims of this study will be to measure: 1. the mechanical properties of the sNPWT device and 2. the adverse events associated with the sNPWT device.

Interventions

DEVICEsimplified negative pressure wound therapy device (Wound Pump device)

A non-powered negative pressure device utilizing a bellows attached to a specialized dressing via drainage tube to promote healing of open wounds.

Sponsors

Center for Integration of Medicine & Innovative Technology
CollaboratorOTHER
Fogarty International Clinical Research Scholarship
CollaboratorUNKNOWN
Brigham and Women's Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
14 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* open wound appropriate for NPWT * wound size greater than 2 cm2 and less than 150 cm2 * adequate adjacent intact skin for application of sNPWT * adequate contour of wound location for application of sNPWT * patient is expected to tolerate change of the NPWT dressing with the chosen analgesia and sedation plan by the treating physician * the patient is expected to remain clinically stable for the duration of the study * the patient is to remain hospitalized for the duration of the study * patient or their legal representative is willing and able to sign an IRB-approved informed consent * patient less than 21 years old is willing to sign an approved assent form if able to sign

Exclusion criteria

* exposed blood vessels * ischemic wound * wound with necrotic tissue requiring further debridement at the time of enrollment * infection * acute osteomyelitis * malignancy in the wound * latex or rubber containing product sensitivity

Design outcomes

Primary

MeasureTime frameDescription
Maintenance of Negative Pressure3 daysThe negative pressure being delivered by the device was measured on a daily basis for three days. Maintenance of negative pressure was defined as negative pressure delivery within 75% of the starting negative pressure amount.

Secondary

MeasureTime frameDescription
Number of Participants With Serious Adverse Events3 daysAny adverse events, including bleeding, wound complication, or change in patient condition during the trial period will be recorded.

Countries

Rwanda

Participant flow

Recruitment details

Hospital wards were surveyed daily over the study period for eligible patients. Photographs of wounds ranging from 2-150 cm2 in size and clinical histories were reviewed for study enrollment eligibility criteria.

Pre-assignment details

47 patients consented. 6 did not meet inclusion criteria. 1 voluntarily withdrew. 4 not enrolled due to clinical changes.

Participants by arm

ArmCount
Simplified Negative Pressure Wound Therapy
The simplified Negative Pressure device will be placed on subjects selected from the hospital wards and meeting the eligibility criteria. simplified Negative Pressure device: A non-powered negative pressure device utilizing a bellows which is compressed every eight hours.
41
Total41

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyPhysician Decision3
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicSimplified Negative Pressure Wound Therapy
Age, Customized
14 to 90 Years
41 participants
Region of Enrollment
Rwanda
41 participants
Sex/Gender, Customized
Female
2 participants
Sex/Gender, Customized
Male
2 participants
Sex/Gender, Customized
Unknown
37 participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
1 / 41
serious
Total, serious adverse events
0 / 41

Outcome results

Primary

Maintenance of Negative Pressure

The negative pressure being delivered by the device was measured on a daily basis for three days. Maintenance of negative pressure was defined as negative pressure delivery within 75% of the starting negative pressure amount.

Time frame: 3 days

Population: 85 dressings were applied. 5 applications excluded due to a change in patient condition, unrelated to sNPWT. 9 dressings excluded due to occlusion of the drainage tube. 71 dressings were analyzed in total.

ArmMeasureValue (MEAN)Dispersion
Simplified Negative Pressure Wound TherapyMaintenance of Negative Pressure22.2 hoursStandard Deviation 27
Secondary

Number of Participants With Serious Adverse Events

Any adverse events, including bleeding, wound complication, or change in patient condition during the trial period will be recorded.

Time frame: 3 days

ArmMeasureValue (NUMBER)
Simplified Negative Pressure Wound TherapyNumber of Participants With Serious Adverse Events0 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026